DAVID
NAVARRO ORTEGA
CATEDRÁTICO/A DE UNIVERSIDAD
Jaime
Sanz Caballer
Publicacions en què col·labora amb Jaime Sanz Caballer (16)
2024
-
Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy
Infection
-
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy
Bone Marrow Transplantation, Vol. 59, Núm. 1, pp. 93-100
2023
2021
-
An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
Journal of Medical Virology, Vol. 93, Núm. 8, pp. 4773-4779
-
Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation
Transplant Infectious Disease, Vol. 23, Núm. 3
-
Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
The Journal of infectious diseases, Vol. 223, Núm. 9, pp. 1564-1575
2020
-
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation
Transplant Infectious Disease, Vol. 22, Núm. 4
-
Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens
Journal of Infection
-
Cytomegalovirus DNA load monitoring in stool specimens for anticipating the occurrence of intestinal acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: Is it of any value?
Transplant Infectious Disease, Vol. 22, Núm. 6
-
The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation
Journal of Infection, Vol. 80, Núm. 3, pp. 333-341
-
The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
Bone Marrow Transplantation, Vol. 55, Núm. 2, pp. 431-440
-
Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors
Bone Marrow Transplantation, Vol. 55, Núm. 11, pp. 2147-2159
2019
-
Clinical Effectiveness of Influenza Vaccination after Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study
Clinical Infectious Diseases, Vol. 68, Núm. 11, pp. 1894-1903
-
Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients
Transplant Infectious Disease, Vol. 21, Núm. 5
-
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
Journal of Infection, Vol. 78, Núm. 5, pp. 393-401